These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 21630254)

  • 1. The synergistic therapeutic effect of cisplatin with Human papillomavirus E6/E7 short interfering RNA on cervical cancer cell lines in vitro and in vivo.
    Jung HS; Erkin OC; Kwon MJ; Kim SH; Jung JI; Oh YK; Her SW; Ju W; Choi YL; Song SY; Kim JK; Kim YD; Shim GY; Shin YK
    Int J Cancer; 2012 Apr; 130(8):1925-36. PubMed ID: 21630254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenes.
    Gu W; Putral L; Hengst K; Minto K; Saunders NA; Leggatt G; McMillan NA
    Cancer Gene Ther; 2006 Nov; 13(11):1023-32. PubMed ID: 16810314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumor injection of small interfering RNA-targeting human papillomavirus 18 E6 and E7 successfully inhibits the growth of cervical cancer.
    Fujii T; Saito M; Iwasaki E; Ochiya T; Takei Y; Hayashi S; Ono A; Hirao N; Nakamura M; Kubushiro K; Tsukazaki K; Aoki D
    Int J Oncol; 2006 Sep; 29(3):541-8. PubMed ID: 16865269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional gene silencing of HPV16 E6/E7 induces growth inhibition via apoptosis in vitro and in vivo.
    Zhou J; Peng C; Li B; Wang F; Zhou C; Hong D; Ye F; Cheng X; Lü W; Xie X
    Gynecol Oncol; 2012 Feb; 124(2):296-302. PubMed ID: 22056554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Papillomavirus E6/E7-Specific siRNA Potentiates the Effect of Radiotherapy for Cervical Cancer in Vitro and in Vivo.
    Jung HS; Rajasekaran N; Song SY; Kim YD; Hong S; Choi HJ; Kim YS; Choi JS; Choi YL; Shin YK
    Int J Mol Sci; 2015 May; 16(6):12243-60. PubMed ID: 26035754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cervical cancer cell growth in vitro and in vivo by lentiviral-vector mediated shRNA targeting the common promoter of HPV16 E6 and E7 oncogenes.
    Zhou J; Li B; Peng C; Wang F; Fu Z; Zhou C; Hong D; Ye F; Lü W; Xie X
    Antiviral Res; 2013 May; 98(2):305-13. PubMed ID: 23523766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of simultaneous silencing of HPV-18 E6 and E7 on inducing apoptosis in HeLa cells.
    Qi Z; Xu X; Zhang B; Li Y; Liu J; Chen S; Chen G; Huo X
    Biochem Cell Biol; 2010 Aug; 88(4):697-704. PubMed ID: 20651842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combinational effect of E6/E7 siRNA and anti-miR-182 on apoptosis induction in HPV16-positive cervical cells.
    Javadi H; Lotfi AS; Hosseinkhani S; Mehrani H; Amani J; Soheili ZS; Hojati Z; Kamali M
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):727-736. PubMed ID: 29873516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatin.
    Putral LN; Bywater MJ; Gu W; Saunders NA; Gabrielli BG; Leggatt GR; McMillan NA
    Mol Pharmacol; 2005 Nov; 68(5):1311-9. PubMed ID: 16120770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
    Munagala R; Aqil F; Jeyabalan J; Gupta RC
    Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
    Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
    Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of cell death in human papillomavirus 18-positive cervical cancer cells by E6 siRNA.
    Yamato K; Fen J; Kobuchi H; Nasu Y; Yamada T; Nishihara T; Ikeda Y; Kizaki M; Yoshinouchi M
    Cancer Gene Ther; 2006 Mar; 13(3):234-41. PubMed ID: 16138119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer.
    Jonson AL; Rogers LM; Ramakrishnan S; Downs LS
    Gynecol Oncol; 2008 Nov; 111(2):356-64. PubMed ID: 18755502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
    Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
    Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic delivery of siRNA by actively targeted polyion complex micelles for silencing the E6 and E7 human papillomavirus oncogenes.
    Nishida H; Matsumoto Y; Kawana K; Christie RJ; Naito M; Kim BS; Toh K; Min HS; Yi Y; Matsumoto Y; Kim HJ; Miyata K; Taguchi A; Tomio K; Yamashita A; Inoue T; Nakamura H; Fujimoto A; Sato M; Yoshida M; Adachi K; Arimoto T; Wada-Hiraike O; Oda K; Nagamatsu T; Nishiyama N; Kataoka K; Osuga Y; Fujii T
    J Control Release; 2016 Jun; 231():29-37. PubMed ID: 26979870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papilloma virus 16 E6 RNA interference enhances cisplatin and death receptor-mediated apoptosis in human cervical carcinoma cells.
    Tan S; Hougardy BM; Meersma GJ; Schaap B; de Vries EG; van der Zee AG; de Jong S
    Mol Pharmacol; 2012 May; 81(5):701-9. PubMed ID: 22328720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eradication of cervical cancer in vivo by an AAV vector that encodes shRNA targeting human papillomavirus type 16 E6/E7.
    Sato N; Saga Y; Uchibori R; Tsukahara T; Urabe M; Kume A; Fujiwara H; Suzuki M; Ozawa K; Mizukami H
    Int J Oncol; 2018 Mar; 52(3):687-696. PubMed ID: 29344635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy.
    Hu Z; Ding W; Zhu D; Yu L; Jiang X; Wang X; Zhang C; Wang L; Ji T; Liu D; He D; Xia X; Zhu T; Wei J; Wu P; Wang C; Xi L; Gao Q; Chen G; Liu R; Li K; Li S; Wang S; Zhou J; Ma D; Wang H
    J Clin Invest; 2015 Jan; 125(1):425-36. PubMed ID: 25500889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the anti-cancer efficacy of lipid nanoparticles containing siRNA against HPV16 E6/E7 combined with cisplatin in a xenograft model of cervical cancer.
    Kang SW; Kang OJ; Lee JY; Kim H; Jung H; Kim H; Lee SW; Kim YM; Choi EK
    PLoS One; 2024; 19(2):e0298815. PubMed ID: 38363779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
    Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
    Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.